3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
10
Rectal Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Sarcoma
8
Stomach Neoplasms
7
Esophageal Neoplasms
7
Breast Neoplasms
7
Neoplasms
5
Lung Neoplasms
5
Hypopharyngeal Neoplasms
5
Carcinoma, Hepatocellular
5
Recurrence
4
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Oropharyngeal Neoplasms
4
Neoplasm Metastasis
4
Thyroid Neoplasms
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Glioma
3
Glioblastoma
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Osteosarcoma
2
Mouth Neoplasms
2
Hyperthermia
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Interventions
Carboplatin
4
pertuzumab
2
durvalumab
2
Tretinoin
2
Trastuzumab
2
Standard of Care
2
Paclitaxel
2
Oxaliplatin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
toripalimab
1
tislelizumab
1
talazoparib
1
sarilumab
1
relugolix
1
regorafenib
1
pexidartinib
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
nimotuzumab
1
neratinib
1
ganitumab
1
enzalutamide
1
dostarlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pathologic Complete Response
×
Surgical Procedures, Operative
×
Clear all
NCT03125343
2023-11-07
WoW
Sahlgrenska University Hospital
Phase NA
Recruiting
400 enrolled